Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03529019 · ClinicalTrials.gov registry record · Early Phase 1
Nutrition in Patient With Critical Limb Ischemia
A Early Phase 1 study of Critical Limb Ischemia and Malnutrition, sponsored by Boston Medical Center.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03529019 is a Early Phase 1 study of Critical Limb Ischemia and Malnutrition that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 30 participants, below the 90-participant average among 18 other Critical Limb Ischemia trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03529019, a Early Phase 1 study of Critical Limb Ischemia and Malnutrition, is actively recruiting participants, sponsored by Boston Medical Center.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective pilot study examining nutritional supplements among vascular surgery patients with Critical Limb Ischemia (CLI). CLI patients have a high rate of malnutrition and has the potential to benefit greatly from nutritional intervention. The investigators plan to evaluate nutrition and functional status of patients by assessing objective lab values and the use of the hand grip strength test. Providing perioperative nutritional supplements to patients has potentially improved their nutritional status, which in turn may improve the patient's clinical status after surgery.
Conditions Studied
Interventions
- DRUG Ensure Surgery Immunonutrition Shake
- DRUG Ensure Enlive Advanced Nutrition Shake
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-10-02 |
| Est. Completion | 2026-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03529019
The ClinicalTrials.gov registry entry for NCT03529019 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 18 other Critical Limb Ischemia trials with a reported enrollment target (67% lower). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Critical Limb Ischemia appearing as the primary indexed condition, and to 2 interventions - of which Ensure Surgery Immunonutrition Shake is the first listed.
NCT03529019 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03529019 about?
NCT03529019 is a clinical study titled "Nutrition in Patient With Critical Limb Ischemia". A prospective pilot study examining nutritional supplements among vascular surgery patients with Critical Limb Ischemia (CLI). CLI patients have a high rate of malnutrition and has the potential to benefit greatly from nutritional intervention. The investigators plan to evaluate nutrition and functi...
What is the current status of trial NCT03529019?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2018-10-02. Estimated completion is 2026-06.
What conditions does trial NCT03529019 study?
This clinical trial studies the following conditions: Critical Limb Ischemia, Malnutrition, Nutritional Supplements.
What interventions are being tested in trial NCT03529019?
The interventions under investigation include: Ensure Surgery Immunonutrition Shake (DRUG), Ensure Enlive Advanced Nutrition Shake (DRUG).
Who is sponsoring clinical trial NCT03529019?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03529019 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Limb Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MOTIV BTK Randomized Controlled Trial
RECRUITING · NA
-
Trial to Assess Chelation Therapy in Critical Limb Ischemia
RECRUITING · Phase 3
-
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
RECRUITING · NA
-
Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention
RECRUITING
-
CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
RECRUITING
-
Serrantor OCT Study
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.